Pentagrit Discovery
Pentagrit Discovery is an India-based zebrafish CRO providing preclinical drug discovery and toxicology services, including target validation, PK/biodistribution, efficacy screening, and AI-assisted histology, to pharmaceutical, biotechnology, and agrochemical clients globally.
- Company typePrivate
- Founded2011
- HeadquartersChennai, India
- Headcount11–50
- GTM typeB2B
- OfferingServices
Pentagrit Discovery firmographics
Firmographics- Name
- Pentagrit Discovery
- Legal name
- Pentagrit
- Website
- https://pentagrit.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Pentagrit Discovery is an India-based zebrafish CRO providing preclinical drug discovery and toxicology services, including target validation, PK/biodistribution, efficacy screening, and AI-assisted histology, to pharmaceutical, biotechnology, and agrochemical clients globally.
- Ownership category
- akta.pro rank
Pentagrit Discovery industry classification
Industry- Product category
- Preclinical Contract Research Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- In Vivo Pharmacology (Efficacy/PD Models) (HLAGAFAA)
- akta.pro secondary industries
- In Vivo Discovery & Translational Models Platforms (humanized models, PK/PD, efficacy) (HLAAAIAK), Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation) (HLAAAIAI), AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening) (HLAAAIAE), DMPK / ADME & Bioanalysis (HLAGAFAC), Drug Discovery (Target ID/Validation & Hit Discovery) (HLAIALAA)
Keywords
Where Pentagrit Discovery is headquartered
LocationHeadquarters
- HQ city
- Chennai
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
Pentagrit Discovery business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Contract Research Services: Project-based preclinical research contracts providing zebrafish-based drug discovery, efficacy screening, PK/biodistribution studies, and toxicology assessment services to pharmaceutical and biotech companies
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Pentagrit Discovery product offering
Product offeringCore offering
Pentagrit Discovery is a Contract Research Organization providing zebrafish-based preclinical drug discovery services to pharmaceutical, biotechnology, and agrochemical clients. The company delivers target engagement validation, PK/biodistribution studies, efficacy screening, phenotype rescue behavioral assays, AI-integrated machine interface systems, and a broad disease model library across neuro, metabolic, muscular, rare, eye, inflammation, and tumor indications. Toxicology services cover acute, chronic, reproductive, developmental, behavioral, and organ-specific assessments, with 140+ studies delivered annually on a 60-day standard turnaround.
Product overview
Pentagrit Discovery is a Zebrafish CRO (Contract Research Organization) offering a comprehensive platform of drug discovery services using zebrafish as the primary research model. The company provides an integrated portfolio including Target Engagement (knock-out lines), PK/Biodistribution (DMPK Services), Efficacy Screening, Phenotype Rescue (Behaviour Assays), Agro Discovery, Machine Interface (Zebrafish AI Systems), and characterized Zebrafish Strains. Their discovery platforms cover specific therapeutic areas including MASH, Obesity, NF1, CART, and SSRI screening. The company also maintains extensive disease model libraries spanning Neurodegeneration, Metabolic, Muscular, Rare, Eye, Inflammation, and Tumor categories. Toxicology services include Acute/Chronic, Reproductive, Developmental, Behavioral, and Organ-Specific Toxicity testing. All services leverage zebrafish genetic variants with AI-powered analysis of full functional physiology.
Differentiator
Problem solved
Functional benefit
Products and services
- Target Engagement (Knock-Out Lines)
Quantifiable outcome
- 60-day study turnaround time
- +3 more outcomes
Companies that use Pentagrit Discovery
Customer profileSegments3 records
Ideal customer profiles3 records
Pentagrit Discovery technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability6 records
Feature6 records
Pentagrit Discovery partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- AD InstrumentscorePentagrit adopted the Powerlab Software System from AD Instruments for real-time data acquisition and analysis in neuronal circuitry research. This integration enhances early discovery services in neurology and deep learning capabilities for AI and technology domains.
Scale indicators6 records
Recent moves5 records
Expansion highlights5 records
Pentagrit Discovery competitors and assessment
Company assessmentBroad incumbents
- Evotec: Global drug discovery and development CRO with end-to-end preclinical and clinical capabilities. Competes broadly with Pentagrit for outsourced discovery work, though zebrafish is one of many platforms rather than its core focus.
- WuXi AppTec: Global CRO/CDMO providing preclinical research, DMPK, toxicology, and discovery services. Overlaps with Pentagrit in outsourced preclinical offerings to pharma, at much larger scale and broader service breadth.
- Inotiv: Preclinical CRO and research models provider with toxicology, safety, and discovery services including alternative model organisms. Competes with Pentagrit for outsourced preclinical work but at significantly larger scale and broader scope.
- Charles River Laboratories: Large-scale preclinical CRO offering safety assessment, DMPK, and discovery services globally. Broader portfolio than Pentagrit with significant zebrafish and alternative model capabilities, but specializes across many non-zebrafish modalities.
- Eurofins Scientific: Global life sciences testing CRO offering preclinical, discovery, and central laboratory services. Competes for outsourced preclinical study contracts from pharma, though zebrafish is one of many alternative model offerings.
Direct peers
- ZeClinics: European zebrafish CRO offering preclinical drug discovery and toxicology services. Directly comparable to Pentagrit in model organism (zebrafish), service mix (efficacy, safety, target validation), and B2B CRO delivery to pharma and biotech clients.
- Crown Bioscience: Global preclinical CRO with established zebrafish and translational oncology platforms. Comparable in providing zebrafish-based in vivo pharmacology services to pharma and biotech, with broader therapeutic area coverage.
- Hunter Biotechnology: China-based zebrafish CRO specializing in preclinical drug safety and efficacy evaluation under OECD/GLP standards. Direct competitor to Pentagrit with overlapping zebrafish toxicology and efficacy screening offerings for global pharma sponsors.
Regional players
- TCG Lifesciences: India-based CRO providing drug discovery and development services across multiple therapeutic areas. Same geographic base as Pentagrit and overlapping preclinical CRO customer segments, with broader integrated discovery-to-development offering.
- Syngene International: India-headquartered integrated CRO/CDMO offering discovery, development, and manufacturing services. Same geographic base as Pentagrit and overlapping preclinical CRO customer base, though broader therapeutic and modality coverage.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights1 record
Customer concentration
Pentagrit Discovery social profiles
Digital presencePentagrit Discovery compliance and trust
Trust signalCompliance2 records
Pentagrit Discovery financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pentagrit Discovery leadership team
Management profileNumber of profiles
Profiles9 records
Pentagrit Discovery funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pentagrit Discovery M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pentagrit Discovery
What does Pentagrit Discovery do?
Pentagrit Discovery is a Contract Research Organization providing zebrafish-based preclinical drug discovery services to pharmaceutical, biotechnology, and agrochemical clients. The company delivers target engagement validation, PK/biodistribution studies, efficacy screening, phenotype rescue behavioral assays, AI-integrated machine interface systems, and a broad disease model library across neuro, metabolic, muscular, rare, eye, inflammation, and tumor indications. Toxicology services cover acute, chronic, reproductive, developmental, behavioral, and organ-specific assessments, with 140+ studies delivered annually on a 60-day standard turnaround.
Is Pentagrit Discovery a public or private company?
Pentagrit Discovery is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Pentagrit Discovery founded?
Pentagrit Discovery was founded in 2011. It employs 11 to 50 people.
Where is Pentagrit Discovery based?
Pentagrit Discovery is headquartered in Chennai, India, in the Asia region.
How does Pentagrit Discovery make money?
One revenue line is on record: contract Research Services.
Who are Pentagrit Discovery's main competitors?
Broad incumbents on record are Evotec, WuXi AppTec, Inotiv, Charles River Laboratories and Eurofins Scientific. Direct peers are ZeClinics, Crown Bioscience and Hunter Biotechnology. Regional players are TCG Lifesciences and Syngene International.
Does Pentagrit Discovery have an API?
No public API is recorded for Pentagrit Discovery.
What industry is Pentagrit Discovery in?
Pentagrit Discovery's product category is Preclinical Contract Research Services. Its primary akta.pro industry code is HLAGAFAA, In Vivo Pharmacology (Efficacy/PD Models), with a secondary code of HLAAAIAK, In Vivo Discovery & Translational Models Platforms (humanized models, PK/PD, efficacy). Its NAICS code is 541714 and its SIC code is 8731.